Melanoma-associated antigen 4 is a protein that in humans is encoded by the MAGEA4gene.[1][2]
This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. At least four variants encoding the same protein have been found for this gene.[2]
References
↑Rogner UC, Wilke K, Steck E, Korn B, Poustka A (Mar 1996). "The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28". Genomics. 29 (3): 725–31. doi:10.1006/geno.1995.9945. PMID8575766.
Brasseur F, Rimoldi D, Liénard D, et al. (1995). "Expression of MAGE genes in primary and metastatic cutaneous melanoma". Int. J. Cancer. 63 (3): 375–80. doi:10.1002/ijc.2910630313. PMID7591235.
Imai Y, Shichijo S, Yamada A, et al. (1995). "Sequence analysis of the MAGE gene family encoding human tumor-rejection antigens". Gene. 160 (2): 287–90. doi:10.1016/0378-1119(94)00680-Q. PMID7642112.
De Plaen E, Arden K, Traversari C, et al. (1994). "Structure, chromosomal localization, and expression of 12 genes of the MAGE family". Immunogenetics. 40 (5): 360–9. doi:10.1007/BF01246677. PMID7927540.
Ding M, Beck RJ, Keller CJ, Fenton RG (1994). "Cloning and analysis of MAGE-1-related genes". Biochem. Biophys. Res. Commun. 202 (1): 549–55. doi:10.1006/bbrc.1994.1963. PMID8037761.
De Plaen E, Naerhuyzen B, De Smet C, et al. (1997). "Alternative promoters of gene MAGE4a". Genomics. 40 (2): 305–13. doi:10.1006/geno.1996.4566. PMID9119398.
Hillig RC, Coulie PG, Stroobant V, et al. (2001). "High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene". J. Mol. Biol. 310 (5): 1167–76. doi:10.1006/jmbi.2001.4816. PMID11502003.
Yutani S, Tanaka M, Mutsumoto H, et al. (2005). "Elevation of serum MAGE-4 protein levels and prediction of hepatocellular carcinogenesis in patients with liver cirrhosis". Jpn. J. Cancer Res. 93 (4): 453–8. doi:10.1111/j.1349-7006.2002.tb01277.x. PMID11985796.
Kocher T, Zheng M, Bolli M, et al. (2002). "Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study". Int. J. Cancer. 100 (6): 702–5. doi:10.1002/ijc.10540. PMID12209610.
Resnick MB, Sabo E, Kondratev S, et al. (2002). "Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinosarcomas and papillary serous carcinomas". Int. J. Cancer. 101 (2): 190–5. doi:10.1002/ijc.10585. PMID12209997.
Nagao T, Higashitsuji H, Nonoguchi K, et al. (2003). "MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity". J. Biol. Chem. 278 (12): 10668–74. doi:10.1074/jbc.M206104200. PMID12525503.
Sarcevic B, Spagnoli GC, Terracciano L, et al. (2003). "Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma". Oncology. 64 (4): 443–9. doi:10.1159/000070305. PMID12759544.
Sakurai T, Itoh K, Higashitsuji H, et al. (2004). "A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells". J. Biol. Chem. 279 (15): 15505–14. doi:10.1074/jbc.M310437200. PMID14739298.
Miyahara Y, Naota H, Wang L, et al. (2006). "Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE". Clin. Cancer Res. 11 (15): 5581–9. doi:10.1158/1078-0432.CCR-04-2585. PMID16061876.
Hudolin T, Juretic A, Spagnoli GC, et al. (2006). "Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue". Prostate. 66 (1): 13–8. doi:10.1002/pros.20312. PMID16114059.
Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID16189514.
Yoshida N, Abe H, Ohkuri T, et al. (2006). "Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance". Int. J. Oncol. 28 (5): 1089–98. doi:10.3892/ijo.28.5.1089. PMID16596224.
Peikert T, Specks U, Farver C, et al. (2006). "Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis". Cancer Res. 66 (9): 4693–700. doi:10.1158/0008-5472.CAN-05-3327. PMID16651421.